✉ Email this page to a colleague
« Back to Dashboard
Acitretinis the generic ingredient in two branded drugs marketed by Barr Labs Inc, Impax Labs Inc, Mylan, Sigmapharm Labs Llc, Teva Pharms Usa, and Stiefel Labs Inc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.
There are eleven drug master file entries for acitretin. Six suppliers are listed for this compound.
Summary for acitretin
|Drug Master File Entries:
|Finished Product Suppliers / Packagers:
|Raw Ingredient (Bulk) Api Vendors:
|Formulation / Manufacturing:
|Drug price trends for acitretin
|What excipients (inactive ingredients) are in acitretin?
|acitretin excipients list
|acitretin at DailyMed
Recent Clinical Trials for acitretin
Identify potential brand extensions & 505(b)(2) entrants
|Translational Immunology Institute
|Singapore General Hospital
|South Valley University
Pharmacology for acitretin
Medical Subject Heading (MeSH) Categories for acitretin
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.